Vaccines against influenza A (H1N1) pandemic

Archives of Medical Research

Volumn 40, Issue 8, 2009, Pages 693-704

  Valdespino Gomez, Jose Luis ^a   Garcia Garcia, Lourdes ^b   Ponce de León Rosales, Samuel ^a  

^a Laboratorio de Biológicos Y Reactivos de México Birmex   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

Influenza A (H1N1); Vaccines

Indexed keywords

CBER RG 2; IDCDC RG 15; IDCDC RG 18; IDCDC RG 20; IDCDC RG 22; INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 VACCINE; IVR 153; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; NIBRG 121; NIBRG 122; SQUALENE; UNCLASSIFIED DRUG; X 179A; X 181; X 181A;

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG SAFETY; GENETIC REASSORTMENT; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A H1N1; MORTALITY; OCCUPATIONAL HAZARD; PANDEMIC; PREGNANT WOMAN; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; VACCINATION; VACCINE PRODUCTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MEXICO; MIDDLE AGED; PREGNANCY; SEASONS; VACCINATION; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77949670327     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.10.008     Document Type: Article

References (34)

1. World Health Organization.Pandemic (H1N1) 2009-update 67. (accessed October 1, 2009). http://www.who.int/csr/don/2009_09_25/en/index.html.
2. National Center for Biotechnology Information. GenBank sequences from 2009 H1N1influenza outbreak. (accessed May 5, 2009). http://www.ncbi.nlm.nih.gov/genomes/FLU/SwineFlu.html.
3. World Health Organization. Vaccines for the new influenza A(H1N1). (accessed May 9, 2009). http://www.who.int/csr/disease/swineflu/frequently_asked_questions/vaccine_preparedness/en/index.html.
4. A service of the US National Institutes of Health. (accessed September 30, 2009). http://clinicaltrials.gov/ct2/home.
5. PubMed Central. (accessed September 28, 2009). http://www.pubmedcentral.nih.gov.
6. World Health Organization. Availability of two new candidate reassortant vaccine viruses for pandemic (H1N1) 2009 virus vaccine development X-181 and X-181A14. September 2009. (accessed October 1, 2009). http://www.who.int/csr/resources/publications/swineflu/x_181_x_181a.pdf.
7. World Health Organization. Characteristics of the emergent influenza A (H1N1) viruses and recommendations for vaccine development. May 26, 2009.
8. World Health Organization. Pandemic influenza vaccine manufacturing process and timeline. (accessed August 28, 2009). http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090806/en/index.html.
9. World Health Organization. Pandemic influenza vaccines: current status. Pandemic (H1N1) 2009 briefing note 11. (accessed October 1, 2009). http://www.who.int/csr/disease/swineflu/notes/pandemic_influenza_vaccines_20090924/en/index.html.
10. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2009-2010 northern hemisphere influenza season. (accessed August 28, 2009). http://www.who.int/csr/disease/influenza/recommendations2009_10north/en/index.html.
11. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. (accessed August 28, 2009). http://www.who.int/csr/disease/influenza/recommendations2009south/en/index.html.
12. World Health Organization. Summary of available candidate vaccine viruses for development of pandemic (H1N1) 2009 virus vaccines July 31st, 2009. (accessed October 1, 2009). http://www.who.int/csr/resources/publications/swineflu/summary_candidate_vaccine.pdf.
13. World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines. (accessed July 20, 2009). http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090713/en/index.html.
14. World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines. (accessed August 28, 2009). http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090713/en/index.html.
15. Secretaria de Salud. Mexico. (accessed September 28, 2009). http://portal.salud.gob.mx/contenidos/inicio/mapa_sitio.html.
16. Centers for Disease Control and Prevention Use of Influenza A (H1N1) 2009 Monovalent Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2009. Morb Mortal Wkly Rep 2009, 58:1-8.
17. Greenberg M, Lai M, Hartel G, et al. Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine-Preliminary Report. Published at September 10, 2009 (10.1056/NEJMoa0907413) 2009. http://www.nejm.org.
18. Clark T, Pareek M, Hoschler K, et al. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine-Preliminary Report. Published at September 10, 2009 (10.1056/NEJMoa0907650). http://www.nejm.org.
19. García-García L., Valdespino-Gómez J., Lazcano-Ponce E., et al. Partial protection of seasonal trivalent inactivated vaccine against the new A (H1N1) 2009 pandemic influenza. A case control study in Mexico City. BMJ 2009, 339:b3928.
20. http://clinicaltrials.gov/.
21. Dodds L., McNeil S.A., Fell D.B., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007, 176:463-468.
22. Freeman D.W., Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959, 78:1172-1175.
23. Louria D.B., Blumenfeld H.L., Ellis J.T., et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959, 38:213-265.
24. Englund J.A., Mbawuike I.N., Hammill H., et al. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993, 168:647-656.
25. Reuman P.D., Ayoub E.M., Small P.A. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J 1987, 6:398-403.
26. Sumaya C.V., Gibbs R.S. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979, 140:141-146.
27. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58:521-524.
28. Package Insert-Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur, Inc.) (PDF - 228 KB). (accessed October 2, 2009). http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182404.pdf.
29. Pandemic influenza A(H1N1)v vaccines authorised via the core dossier procedure. Explanatory note on scientific considerations regarding the licensing of pandemic A(H1N1) vaccines. (accessed October 2, 2009). http://www.emea.europa.eu/pdfs/human/pandemicinfluenza/60825909en.pdf.
30. Package Insert-Influenza A (H1N1) 2009 Monovalent (Novartis Vaccines and Diagnostics Limited) (PDF-312 KB). (accessed October 2, 2009). http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182242.pdf.
31. World Health Organization. Squalene-based adjuvants in vaccines. (accessed September 30, 2009). http://www.who.int/vaccine_safety/topics/adjuvants/squalene/questions_and_answers/en/index.html.
32. Asa P.B., Cao Y., Garry R.F. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 2000, 68:55-64.
33. Matyas G.R., Rao M., Pittman P.R., et al. Detection of antibodies to squalene. III. Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods 2004, 286:47-67.
34. Neuzil K. Pandemic Influenza Vaccine Policy-Considering the Early Evidence. Published at September 10, 2009 (10.1056/NEJMe0908224) 2009. http://www.nejm.org.